Condition
Hematopoietic Cell Transplantation (HCT) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Hematopoietic Cell Transplantation (HCT) clinical trials that are recruiting, in United States. By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Early Tacrolimus Taper After Allogeneic Transplant
This study tests whether stopping tacrolimus early after an allogeneic stem cell transplant is safe and feasible for people with AML, MDS, MF, CML, CMML, or GVHD risk after transplant.
-
Momelotinib given before and after allogeneic bone marrow transplant for myelofibrosis
This test will see if giving momelotinib around the time of allogeneic hematopoietic cell transplant is safe and tolerable for adults with intermediate- or high-risk myelofibrosis.
Related topics
Quick answers
How many Hematopoietic Cell Transplantation (HCT) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.